Dr. Nancy T. Chang, Ph.D. serves as the President and Chief Executive Officer of Apex Enterprise, Inc. Dr. Chang has more than 30 years of experience in the biophermaceutical industry, successfully developing and commercializing therapeutic and diagnostic products.
Dr. Chang cofounded Tanox in 1986 to address medical needs in the areas of allergy, asthma, inflammation and diseases affecting the human immune system. In June 2003, the U.S. Food and Drug Administration (FDA) approved Xolair, the first biotech product cleared for treating those with asthma related allergies. Dr. Chang successfully grew Tanox from an idea to a substantial publicly traded company which was ultimately sold to Genetech for $919 million.
Throughout her career Dr. Chang has received numerous academic, national and international awards for her business acumen and contributions to the biopharmaceutical industry. She was inducted into the Texas Science Hall of Fame in 2001 for exemplary achievement in science and is the recipient of coveted awards such as the Associate of Women in Computing: Top 20 Houston Women in Technology, Who’s Who National Registry and Houston Entrepreneur of the Year (sponsored by Ernst & Young, Inc. Magazine and Merrill Lynch).
As an Active Member in the Biopharmaceutical Industry, she has published more than 35 papers on topics ranging from monoclonal antibodies to HIV and holds seven patents. She conducted her post-doctoral research at the Roche Institute of Molecular Biology. Dr. Chang received her Doctorate in Biological Chemistry from Harvard University.